Filtros de búsqueda

Lista de obras de

'Chemobrain' in breast carcinoma?: a prologue

artículo científico publicado en 2004

A comparative randomized trial of vinca alkaloids in patients with metastatic breast carcinoma

artículo científico publicado en 1985

A comparative study of PALA, PALA plus 5-FU, and 5-FU in advanced breast cancer

artículo científico publicado en 1985

A comparative study of bisantrene given by two dose schedules in patients with metastatic breast cancer

artículo científico publicado en 1986

A detailed evaluation of cardiac toxicity: a phase II study of doxorubicin and one- or three-hour-infusion paclitaxel in patients with metastatic breast cancer

artículo científico publicado en 2002

A phase I and pharmacokinetic study of TAS-108 in postmenopausal female patients with locally advanced, locally recurrent inoperable, or progressive metastatic breast cancer

artículo científico publicado en 2004

A phase II neoadjuvant trial of sequential nanoparticle albumin-bound paclitaxel followed by 5-fluorouracil/epirubicin/cyclophosphamide in locally advanced breast cancer

artículo científico publicado en 2010

A phase II study of peptichemio in advanced breast cancer

artículo científico publicado en 1980

A phase II study of tipifarnib and gemcitabine in metastatic breast cancer

artículo científico publicado en 2018

A phase III trial of sequential adjuvant chemotherapy for operable breast carcinoma: final analysis with 10-year follow-up

artículo científico publicado en 2003

A prospective trial of preoperative chemotherapy in resectable breast cancer: predictors of breast-conservation therapy feasibility

scientific article published on 01 April 2002

A randomized phase 2 trial comparing 3-hour versus 96-hour infusion schedules of paclitaxel for the treatment of metastatic breast cancer

artículo científico publicado en 2010

A roundtable discussion of aromatase inhibitors as therapy for breast cancer.

artículo científico publicado en 2003

A unified definition of clinical anthracycline resistance breast cancer.

artículo científico publicado en 2000

AMSA and peptichemio in the treatment of advances metastatic breast cancer: a phase II study

artículo científico publicado en 1982

ATAC trial did not report interim results

artículo científico publicado en 2003

Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy

artículo científico publicado en 2006

Accuracy of the combination of mammography and sonography in predicting tumor response in breast cancer patients after neoadjuvant chemotherapy

artículo científico publicado en 2006

Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer

artículo científico publicado en 2010

Adjuvant chemotherapy for breast cancer

artículo científico publicado en 1986

Adjuvant lapatinib for women with early-stage HER2-positive breast cancer: a randomised, controlled, phase 3 trial

artículo científico publicado en 2012

Adjuvant systemic therapy for male breast carcinoma

artículo científico publicado en 2005

Adjuvant therapy of breast cancer with or without additional treatment with alternate drugs

artículo científico publicado en 1988

Adjuvant use of anastrozole in breast cancer

artículo científico publicado en 2004

Adriamycin, dibromodulcitol, and mitomycin combination chemotherapy for patients with metastatic breast carcinoma previously treated with cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisone

artículo científico publicado en 1984

Adverse prognostic significance of infraclavicular lymph nodes detected by ultrasonography in patients with locally advanced breast cancer

artículo científico publicado en 2001

Aggressive therapy for locoregional recurrence after mastectomy in stage II and III breast cancer patients

artículo científico publicado en 1996

Alternating noncross-resistant combination chemotherapy and active nonspecific immunotherapy with BCG or MER-BCG for advanced breast carcinoma.

artículo científico publicado en 1980

Aminoglutethimide after tamoxifen therapy in advanced breast cancer: M. D. Anderson Hospital experience

artículo científico publicado en 1982

Amphotericin B and combination chemotherapy in the treatment of refractory metastatic breast carcinoma and sarcoma.

artículo científico publicado en 1978

An overview of the pharmacology and pharmacokinetics of the newer generation aromatase inhibitors anastrozole, letrozole, and exemestane

artículo científico publicado en 2002

Analysis of dose intensity in doxorubicin-containing adjuvant chemotherapy in stage II and III breast carcinoma

artículo científico publicado en 1989

Anastrozole (Arimidex®), a New Aromatase Inhibitor for Advanced Breast Cancer: Mechanism of Action and Role in Management ⬇️

artículo científico publicado el 1 de enero de 1998

Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction Between SLC38A7 and ALPPL2

artículo científico publicado en 2019

Anastrozole as an adjuvant endocrine treatment for postmenopausal patients with breast cancer: emerging data

artículo científico publicado en 2006

Are aromatase inhibitors superior to antiestrogens?

artículo científico publicado en 2005

Aromatase inhibitors alone or in sequence with tamoxifen - clinical evaluation of the BIG 1-98 trial

artículo científico publicado en 2010

Aromatase inhibitors in metastatic breast cancer.

artículo científico publicado en 1996

Aromatase inhibitors in premenopausal breast cancer

scientific article published on 20 January 2012

Aromatase inhibitors: current status

artículo científico publicado en 1995

Benign versus malignant hepatic lesions. A diagnostic dilemma with breast cancer patients

artículo científico publicado en 1983

Bilateral primary breast cancer in patients treated with adjuvant therapy

artículo científico publicado en 1988

Bioequivalence of 20-mg once-daily tamoxifen relative to 10-mg twice-daily tamoxifen regimens for breast cancer

artículo científico publicado en 1994

Biologic and immunologic effects of preoperative trastuzumab for ductal carcinoma in situ of the breast

artículo científico publicado en 2010

Biologic basis and evolving role of aromatase inhibitors in the management of invasive carcinoma of the breast

artículo científico publicado en 2001

Breast cancer

artículo científico publicado en 1984

Breast cancer in men.

artículo científico publicado en 2002

Breast carcinoma in men: a population-based study

artículo científico publicado en 2004

CD40 signaling predicts response to preoperative trastuzumab and concomitant paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide in HER-2-overexpressing breast cancer

artículo científico publicado en 2007

Carcinoma of the male breast

artículo científico publicado en 1992

Cardiovascular death and second non-breast cancer malignancy after postmastectomy radiation and doxorubicin-based chemotherapy

artículo científico publicado en 2003

Causes of death in breast cancer: a clinicopathologic study

artículo científico publicado en 1980

Central nervous system metastases in patients with high-risk breast carcinoma after multimodality treatment

artículo científico publicado en 2004

Change in tumor cellularity of breast carcinoma after neoadjuvant chemotherapy as a variable in the pathologic assessment of response

artículo científico publicado en 2004

Chemoimmunotherapy for metastatic breast cancer with 5-fluorouracil, adriamycin, cyclophosphamide, methotrexate, L-asparaginase, Corynebacterium parvum, and Pseudomonas vaccine

artículo científico publicado en 1980

Chemotherapy of metastatic breast cancer: what to expect in 2001 and beyond

artículo científico publicado en 2001

Chemotherapy with mitoxantrone in combination with continuous infusion vinblastine for metastatic breast cancer

artículo científico publicado en 1987

Classification of Ipsilateral Breast Tumor Recurrences After Breast Conservation Therapy Can Predict Patient Prognosis and Facilitate Treatment Planning ⬇️

artículo científico publicado el 1 de marzo de 2011

Clinical Trial Characteristics and Barriers to Participant Accrual: The MD Anderson Cancer Center Experience over 30 years, a Historical Foundation for Trial Improvement

artículo científico publicado en 2017

Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy

artículo científico publicado en 1999

Clinical course of breast cancer patients with liver metastases

artículo científico publicado en 1987

Clinical course of breast cancer patients with metastases confined to the lungs treated with chemotherapy. The University of Texas M.D. Anderson Cancer Center experience and review of the literature

scientific article published on 01 April 1998

Clinical course of breast cancer patients with osseous metastasis treated with combination chemotherapy

artículo científico publicado en 1986

Clinical features associated with a favorable outcome following neoadjuvant chemotherapy in women with localized breast cancer aged 35 years or younger

scientific article published on 26 June 2008

Clinical perspectives on the utility of aromatase inhibitors for the adjuvant treatment of breast cancer

artículo científico publicado en 2009

Clinical trial of plasma perfusion over immobilized staphylococcal protein A in metastatic breast cancer

artículo científico publicado en 1987

Clinically relevant pneumonitis after sequential paclitaxel-based chemotherapy and radiotherapy in breast cancer patients

artículo científico publicado en 2004

Colitis associated with docetaxel-based chemotherapy in patients with metastatic breast cancer

artículo científico publicado en 2000

Colitis in patients with breast carcinoma treated with taxane-based chemotherapy

artículo científico publicado en 2004

Collagen IV levels are elevated in the serum of patients with primary breast cancer compared to healthy volunteers

artículo científico publicado en 2008

Combination chemoimmunotherapy of metastatic breast cancer with 5-fluorouracil, adriamycin, cyclophosphamide, and BCG.

artículo científico publicado en 1979

Combination chemoimmunotherapy with FAC‐BCG for metastatic breast cancer: The impact of CMF maintenance chemotherapy ⬇️

artículo científico publicado el 1 de enero de 1981

Combination chemotherapy for metastatic breast cancer with fluorouracil, adriamycin, cyclophosphamide, and methotrexate

artículo científico publicado en 1984

Combination chemotherapy with continuous infusion vinblastine and peptichemio for patients with advanced metastatic breast cancer

scientific article published on 01 October 1982

Combination chemotherapy with paclitaxel and doxorubicin for metastatic breast cancer

artículo científico publicado el 1 de agosto de 1997

Combined antiestrogen and cytotoxic therapy with pseudomonas vaccine immunotherapy for metastatic breast cancer. A prospective, randomized trial

artículo científico publicado en 1987

Combined modality treatment of locally advanced breast carcinoma in elderly patients or patients with severe comorbid conditions using tamoxifen as the primary therapy

scientific article published on 01 May 2000

Combined modality treatment of stage III and inflammatory breast cancer. M.D. Anderson Cancer Center experience

artículo científico publicado en 1995

Combined use of clinical and pathologic staging variables to define outcomes for breast cancer patients treated with neoadjuvant therapy

artículo científico publicado en 2007

Combined-modality treatment for isolated recurrences of breast carcinoma: update on 30 years of experience at the University of Texas M.D. Anderson Cancer Center and assessment of prognostic factors

artículo científico publicado en 2005

Combined-modality treatment of inflammatory breast carcinoma: twenty years of experience at M. D. Anderson Cancer Center ⬇️

artículo científico publicado el 1 de enero de 1997

Comment on 'Long-term tamoxifen adjuvant therapy in node positive breast cancer'

Comparison of anastrozole versus tamoxifen as preoperative therapy in postmenopausal women with hormone receptor-positive breast cancer: the Pre-Operative "Arimidex" Compared to Tamoxifen (PROACT) trial

scientific article published on 01 May 2006

Correlation between HER-2 expression and response to neoadjuvant chemotherapy with 5-fluorouracil, doxorubicin, and cyclophosphamide in patients with breast carcinoma

artículo científico publicado en 2003

Cranial nerve palsies in metastatic breast cancer due to osseous metastasis without intracranial involvement

scientific article published on 01 July 1983

Cytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemotherapy with concurrent trastuzumab for HER2-positive breast cancer

artículo científico publicado en 2010

Decreased cardiac toxicity of doxorubicin administered by continuous intravenous infusion in combination chemotherapy for metastatic breast carcinoma

artículo científico publicado en 1989

Defining the role of aromatase inhibitors in the adjuvant endocrine treatment of early breast cancer

artículo científico publicado en 2006

Dihydroxyanthracenedione: A Promising New Drug in the Treatment of Metastatic Breast Cancer

artículo científico publicado el 1 de diciembre de 1981

Disease-Free and Overall Survival Among Patients With Operable HER2-Positive Breast Cancer Treated With Sequential vs Concurrent Chemotherapy: The ACOSOG Z1041 (Alliance) Randomized Clinical Trial

Disease-free and overall survival after pathologic complete disease remission of cytologically proven inflammatory breast carcinoma axillary lymph node metastases after primary systemic chemotherapy

scientific article published on 01 March 2006

Double-blind, randomized placebo controlled trial of fulvestrant compared with exemestane after prior nonsteroidal aromatase inhibitor therapy in postmenopausal women with hormone receptor-positive, advanced breast cancer: results from EFECT.

artículo científico publicado en 2008

Doxorubicin-based adjuvant chemotherapy in elderly breast cancer patients: the M.D. Anderson experience, with long-term follow-up

scientific article published on 01 December 2000

Doxorubicin-based chemotherapy in elderly patients with metastatic breast cancer. Tolerance and outcome

artículo científico publicado en 1996

Doxorubicin-induced congestive heart failure in elderly patients with metastatic breast cancer, with long-term follow-up: the M.D. Anderson experience

artículo científico publicado en 1999

ESR1 mutations and overall survival on fulvestrant versus exemestane in advanced hormone receptor positive breast cancer: A combined analysis of the phase III SoFEA and EFECT trials

artículo científico publicado en 2020

Early and delayed clinical cardiotoxicity of doxorubicin

artículo científico publicado en 1985

Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial

artículo científico publicado en 2010

Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial

artículo científico publicado en 2008

Effect of timing of initiation of adjuvant chemotherapy on disease-free survival in breast cancer

scientific article published on 01 January 1982

Effectiveness of mastectomy by response to induction chemotherapy for control in inflammatory breast carcinoma ⬇️

artículo científico publicado el 1 de septiembre de 1997

Effects of pregnancy after treatment for breast carcinoma on survival and risk of recurrence

artículo científico publicado en 2004

Efficacy and safety of neoadjuvant trastuzumab combined with paclitaxel and epirubicin: a retrospective review of the M. D. Anderson experience

artículo científico publicado en 2007

Efficacy of anastrozole in male breast cancer

artículo científico publicado en 2002

Efficacy of neoadjuvant therapy with trastuzumab concurrent with anthracycline‐ and nonanthracycline‐based regimens for HER2‐positive breast cancer ⬇️

artículo científico publicado el 27 de septiembre de 2011

Elliptinium acetate in metastatic breast cancer--a phase II study

artículo científico publicado en 1990

Endocrine and targeted manipulation of breast cancer: summary statement for the Sixth Cambridge Conference

artículo científico publicado en 2008

Estrogen Receptor Expression in 21-Gene Recurrence Score Predicts Increased Late Recurrence for Estrogen-Positive/HER2-Negative Breast Cancer

artículo científico publicado en 2015

Estrogen receptors and distinct patterns of breast cancer relapse

scientific article published on 01 March 2003

Estrogens and their precursors in postmenopausal women with early breast cancer receiving anastrozole

artículo científico publicado en 2014

Evaluation of changes in serum protein profiles during neoadjuvant chemotherapy in HER2-positive breast cancer using an LC-MALDI-TOF/MS procedure.

artículo científico publicado en 2010

Evaluation of high-dose versus standard FAC chemotherapy for advanced breast cancer in protected environment units: a prospective randomized study

artículo científico publicado en 1987

Evaluation of paclitaxel in adjuvant chemotherapy for patients with operable breast cancer: preliminary data of a prospective randomized trial.

artículo científico publicado en 2002

Evaluation of polyinosinic-polycytidylic and poly-L-lysine in metastatic breast cancer

artículo científico publicado en 1986

Evaluation of preoperative chemotherapy using PET with fluorine-18-fluorodeoxyglucose in breast cancer

scientific article published on 01 June 1996

Expression of erbB/HER receptors, heregulin and P38 in primary breast cancer using quantitative immunohistochemistry

artículo científico publicado en 2001

FAC + BCG as adjuvant therapy in breast cancer: an 8-year update

scientific article published on 01 January 1984

Factors predicting long-term survival for metastatic breast cancer patients treated with high-dose chemotherapy and bone marrow support

artículo científico publicado en 1994

Factors predictive of distant metastases in patients with breast cancer who have a pathologic complete response after neoadjuvant chemotherapy

artículo científico publicado en 2005

Factors predictive of outcome in patients with breast cancer refractory to neoadjuvant chemotherapy

scientific article published on 01 September 2001

Feasibility of breast preservation in the treatment of occult primary carcinoma presenting with axillary metastases

artículo científico publicado en 2001

Female patients with breast carcinoma age 30 years and younger have a poor prognosis: the M.D. Anderson Cancer Center experience

artículo científico publicado en 2001

Fifteen-year results of a randomized prospective trial of hyperfractionated chest wall irradiation versus once-daily chest wall irradiation after chemotherapy and mastectomy for patients with locally advanced noninflammatory breast cancer

scientific article published on 05 June 2006

Fluorouracil, doxorubicin, and cyclophosphamide followed by tamoxifen as adjuvant treatment for patients with stage IV breast cancer with no evidence of disease

artículo científico publicado en 2002

Fluorouracil, epirubicin, and cyclophosphamide (FEC-75) followed by paclitaxel plus trastuzumab versus paclitaxel plus trastuzumab followed by FEC-75 plus trastuzumab as neoadjuvant treatment for patients with HER2-positive breast cancer (Z1041): a r

Fulvestrant versus anastrozole for the treatment of advanced breast carcinoma in postmenopausal women: a prospective combined analysis of two multicenter trials

artículo científico publicado en 2003

Functional genetic polymorphisms in the aromatase gene CYP19 vary the response of breast cancer patients to neoadjuvant therapy with aromatase inhibitors

artículo científico publicado en 2010

Genomic characterization of HER2-positive breast cancer and response to neoadjuvant trastuzumab and chemotherapy-results from the ACOSOG Z1041 (Alliance) trial

artículo científico

Health related quality of life of women in TEACH, a randomised placebo controlled adjuvant trial of lapatinib in early stage Human Epidermal Growth Factor Receptor (HER2) overexpressing breast cancer

artículo científico publicado en 2015

Hematologic adverse effects of aminoglutethimide

scientific article published on 01 January 1984

Her2/neu-positive disease does not increase risk of locoregional recurrence for patients treated with neoadjuvant doxorubicin-based chemotherapy, mastectomy, and radiotherapy.

artículo científico publicado en 2004

High-dose 1-beta-D-arabinofuranosylcytosine in advanced breast cancer

artículo científico publicado en 1985

High-dose chemotherapy with autologous stem cell support in patients with breast cancer ⬇️

artículo científico publicado el 1 de agosto de 1998

High-dose induction chemotherapy of metastatic breast cancer in protected environment: a prospective randomized study

artículo científico publicado en 1987

Hormone receptor status and pathologic response of HER2-positive breast cancer treated with neoadjuvant chemotherapy and trastuzumab.

artículo científico publicado en 2008

Hormone receptors in breast cancer and response to chemotherapy

artículo científico publicado en 1979

Identification of early breast cancer patient cohorts who may benefit from lapatinib therapy

artículo científico publicado en 2016

Immediate and long-term toxicity of adjuvant chemotherapy regimens containing doxorubicin in trials at M.D. Anderson Hospital and Tumor Institute

artículo científico publicado en 1986

Immune-complex glomerulonephritis secondary to nonspecific immunotherapy

artículo científico publicado en 1980

Immunohistochemical BAG1 expression improves the estimation of residual risk by IHC4 in postmenopausal patients treated with anastrazole or tamoxifen: a TransATAC study.

artículo científico

Impact of chemotherapy regimens prior to endocrine therapy: Results from the ATAC (Anastrozole and Tamoxifen, Alone or in Combination) trial

artículo científico publicado en 2006

Impact of multicentricity on clinical outcome in patients with T1-2, N0-1, M0 breast cancer

scientific article published on 01 September 2000

Impact of patient characteristics on treatment outcome: Anthracycline resistance ⬇️

artículo científico publicado el 1 de agosto de 1997

Impact of preoperative versus postoperative chemotherapy on the extent and number of surgical procedures in patients treated in randomized clinical trials for breast cancer

artículo científico publicado en 2006

Impact of race, ethnicity, and BMI on achievement of pathologic complete response following neoadjuvant chemotherapy for breast cancer: a pooled analysis of four prospective Alliance clinical trials (A151426).

artículo científico publicado en 2016

Impact of selection process on response rate and long-term survival of potential high-dose chemotherapy candidates treated with standard-dose doxorubicin-containing chemotherapy in patients with metastatic breast cancer ⬇️

artículo científico publicado el 1 de octubre de 1997

Impact of systemic treatment on local control for patients with lymph node-negative breast cancer treated with breast-conservation therapy

artículo científico publicado en 2001

Improved survival of patients with metastatic breast cancer receiving combination chemotherapy

artículo científico publicado en 1985

Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy

artículo científico publicado en 1999

Inclusion of taxanes, particularly weekly paclitaxel, in preoperative chemotherapy improves pathologic complete response rate in estrogen receptor-positive breast cancers

artículo científico publicado en 2007

Indium-111-labeled B72.3 monoclonal antibody in the detection and staging of breast cancer: a phase I study

artículo científico publicado en 1991

Induction chemotherapy of breast cancer.

artículo científico publicado en 1985

Inflammatory Breast Cancer Survival: The Role of Obesity and Menopausal Status at Diagnosis

artículo científico publicado en 2000

Inflammatory breast cancer (IBC) and patterns of recurrence: understanding the biology of a unique disease

artículo científico publicado en 2007

Inflammatory carcinoma of the breast: results of a combined-modality approach--M.D. Anderson Cancer Center experience

artículo científico publicado en 1990

Influence of Comorbidities and Age on Risk of Death Without Recurrence: A Retrospective Analysis of the Arimidex, Tamoxifen Alone or in Combination Trial

article

Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes

artículo científico publicado en 2005

Is breast cancer survival improving?

artículo científico publicado en 2004

Is chemotherapy effective in reducing the local failure rate in patients with operable breast cancer?

artículo científico publicado en 1990

Kinetics of serum HER-2/neu changes in patients with HER-2-positive primary breast cancer after initiation of primary chemotherapy

artículo científico publicado en 2007

Lack of association between amplification of her-2 and response to preoperative taxanes in patients with breast carcinoma

artículo científico publicado en 2004

Letrozole or tamoxifen in early breast cancer

artículo científico publicado en 2006

Locally Advanced Breast Cancer

artículo científico publicado en 1996

Locally advanced noninflammatory breast cancer

scientific article published on 01 April 1996

Locoregional Recurrence Risk for Patients With T1,2 Breast Cancer With 1-3 Positive Lymph Nodes Treated With Mastectomy and Systemic Treatment

artículo científico publicado en 2014

Locoregional irradiation for inflammatory breast cancer: effectiveness of dose escalation in decreasing recurrence

artículo científico publicado en 2000

Locoregional recurrence after doxorubicin-based chemotherapy and postmastectomy: Implications for breast cancer patients with early-stage disease and predictors for recurrence after postmastectomy radiation

artículo científico publicado en 2003

Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation

artículo científico publicado en 2000

Locoregional treatment outcomes for inoperable anthracycline-resistant breast cancer.

artículo científico publicado en 2002

Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype

artículo científico publicado en 2017

Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer

scientific article published on 01 August 1996

Long-term hazard of recurrence in HER2+ breast cancer patients untreated with anti-HER2 therapy

artículo científico publicado en 2015

Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: The University of Texas M.D. Anderson Cancer Center experience

artículo científico publicado en 2001

Longitudinal nail banding associated with breast carcinoma unrelated to chemotherapy

scientific article published on 01 August 1978

Lorazepam-enhancement of the antiemetic efficacy of dexamethasone and promethazine. A placebo-controlled study

scientific article published on 01 October 1994

Loss of HER2 amplification following trastuzumab-based neoadjuvant systemic therapy and survival outcomes

artículo científico publicado en 2009

Making Genuine Progress Against Metastatic Breast Cancer ⬇️

artículo científico publicado el 27 de agosto de 2012

Mammographic breast density response to aromatase inhibition

artículo científico publicado en 2013

Management of breast cancer during pregnancy using a standardized protocol

scientific article published on 01 March 1999

Management of breast cancer patients failing adjuvant chemotherapy with adriamycin-containing regimens

scientific article published on 01 June 1981

Management of inflammatory breast cancer

artículo científico publicado en 1994

Management of inflammatory carcinoma of breast with combined modality approach - an update

scientific article published on 01 June 1981

Management of inflammatory carcinoma of the breast. A combined modality approach

scientific article published on 01 April 1985

Management of locally advanced breast cancer

artículo científico publicado en 1988

Management of locoregional recurrent breast cancer

scientific article published on 01 October 1986

Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy

artículo científico publicado en 1988

Measurement of estrogen and progesterone receptors in human breast tumors: enzyme immunoassay versus binding assay

artículo científico publicado en 1990

Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy.

artículo científico publicado en 2007

Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen

artículo científico publicado en 2009

Mitomycin in metastatic breast cancer refractory to hormonal and combination chemotherapy

artículo científico publicado en 1985

Mitoxantrone, cyclophosphamide, and 5-fluorouracil in the treatment of hormonally unresponsive metastatic breast cancer

artículo científico publicado en 1984

Mitoxantrone, cyclophosphamide, and fluorouracil in metastatic breast cancer unresponsive to hormonal therapy

artículo científico publicado en 1987

Modifying the Clinical Research Infrastructure at a Dedicated Clinical Trials Unit: Assessment of Trial Development, Activation, and Participant Accrual

artículo científico publicado en 2016

Multimodal treatment for inflammatory breast cancer

artículo científico publicado en 1989

Multimodal treatment of locoregionally advanced breast cancer

scientific article published on 01 March 1983

Multivariate analysis of prognostic factors in metastatic breast cancer

artículo científico publicado en 1983

Neoadjuvant therapy with paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide chemotherapy and concurrent trastuzumab in human epidermal growth factor receptor 2-positive operable breast cancer: an update of the initial randomized

artículo científico publicado en 2007

Nomograms to predict pathologic complete response and metastasis-free survival after preoperative chemotherapy for breast cancer

artículo científico publicado en 2005

Noninvasive cardiac evaluation of patients receiving adriamycin-containing adjuvant chemotherapy (FAC) for stage II or III breast cancer

artículo científico publicado en 1983

Novel clinical trial designs for treatment of ductal carcinoma in situ of the breast with trastuzumab (herceptin)

scientific article published on 01 January 2007

Novel staging system for predicting disease-specific survival in patients with breast cancer treated with surgery as the first intervention: time to modify the current American Joint Committee on Cancer staging system.

artículo científico publicado en 2011

Obesity as an adverse prognostic factor for patients receiving adjuvant chemotherapy for breast cancer

artículo científico publicado en 1994

Optimum use of aromatase inhibitors in the adjuvant treatment of early breast cancer

scientific article published on 01 November 2005

Oral medroxyprogesterone acetate in the treatment of metastatic breast cancer

scientific article published on 01 January 1985

Osteoblastic metastatic disease as a therapeutic response to adjuvant chemotherapy in breast cancer

artículo científico publicado en 1983

Outcome after pathologic complete eradication of cytologically proven breast cancer axillary node metastases following primary chemotherapy

scientific article published on 01 December 2005

Paclitaxel by 24-hour infusion with doxorubicin by 48-hour infusion as initial therapy for metastatic breast cancer: phase I results

artículo científico publicado en 1999

Paclitaxel improves the prognosis in estrogen receptor negative inflammatory breast cancer: the M. D. Anderson Cancer Center experience

artículo científico publicado en 2004

Paclitaxel in the multimodality treatment for inflammatory breast carcinoma

artículo científico publicado en 2001

Paclitaxel in the treatment of metastatic breast cancer: M.D. Anderson Cancer Center experience

artículo científico publicado en 1995

Pathologic complete response to neoadjuvant chemotherapy with trastuzumab predicts for improved survival in women with HER2-overexpressing breast cancer

artículo científico publicado en 2013

Pathologic tumor response in the breast following neoadjuvant chemotherapy predicts axillary lymph node status

artículo científico publicado el 1 de julio de 1998

Pathologic tumor size and lymph node status predict for different rates of locoregional recurrence after mastectomy for breast cancer patients treated with neoadjuvant versus adjuvant chemotherapy

artículo científico publicado en 2002

Pathological assessment of response to induction chemotherapy in breast cancer

artículo científico publicado en 1986

Peptichemio versus melphalan (L-PAM) in advanced breast cancer

artículo científico publicado en 1982

Percutaneous hepatic arterial infusion of cisplatin-vinblastine for refractory breast carcinoma metastatic to the liver

artículo científico publicado en 1988

Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer

artículo científico publicado en 2006

Pharmacogenomics of aromatase inhibitors in postmenopausal breast cancer and additional mechanisms of anastrozole action

scientific article published on 23 July 2020

Phase I study of vinorelbine and paclitaxel by 3-hour simultaneous infusion with and without granulocyte colony-stimulating factor support in metastatic breast carcinoma

artículo científico publicado en 2001

Phase I study of vinorelbine by 96-hour infusion in advanced metastatic breast cancer

artículo científico publicado en 2000

Phase I trial of droloxifene in patients with metastatic breast cancer.

artículo científico publicado en 1994

Phase I-II vinorelbine (Navelbine) by continuous infusion in patients with metastatic breast cancer: cumulative toxicities limit dose escalation

artículo científico publicado en 2001

Phase I/II trial of high dose mitoxantrone in metastatic breast cancer: the M.D. Anderson Cancer Center experience

artículo científico publicado en 1999

Phase II evaluation of interferon added to tamoxifen in the treatment of metastatic breast cancer.

artículo científico publicado en 1991

Phase II evaluation of vinblastine, methotrexate, and calcium leukovorin rescue in patients with refractory metastatic breast cancer

artículo científico publicado en 1983

Phase II study of AMSA and doxorubicin to treat metastatic breast cancer

artículo científico publicado en 1986

Phase II study of iproplatin in metastatic breast carcinoma

artículo científico publicado en 1987

Phase II study of paclitaxel in patients with metastatic breast carcinoma refractory to standard chemotherapy.

artículo científico publicado en 2000

Phase II study of peplomycin in advanced breast carcinoma

artículo científico publicado en 1987

Phase II study of vinorelbine administered by 96-hour infusion in patients with advanced breast carcinoma.

artículo científico publicado en 1999

Phase II trial of docetaxel: a new, highly effective antineoplastic agent in the management of patients with anthracycline-resistant metastatic breast cancer

artículo científico publicado en 1995

Phase II trial of liposome-encapsulated doxorubicin, cyclophosphamide, and fluorouracil as first-line therapy in patients with metastatic breast cancer

artículo científico publicado en 1999

Phase II, randomized, double-blind study of two dose levels of arzoxifene in patients with locally advanced or metastatic breast cancer

artículo científico publicado en 2003

Phase III Randomized Trial of Dose Intensive Neoadjuvant Chemotherapy with or Without G-CSF in Locally Advanced Breast Cancer: Long-Term Results ⬇️

artículo científico publicado el 31 de octubre de 2011

Phase III Trial Evaluating Weekly Paclitaxel Versus Docetaxel in Combination With Capecitabine in Operable Breast Cancer ⬇️

artículo científico publicado el 13 de febrero de 2012

Phase III double-blind trial of arzoxifene compared with tamoxifen for locally advanced or metastatic breast cancer

artículo científico publicado en 2007

Pirarubicin in combination chemotherapy for metastatic breast cancer

artículo científico publicado en 1990

Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients

artículo científico publicado en 2011

Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy

artículo científico publicado en 2004

Predicting outcome based on Swenerton score in patients with metastatic breast cancer undergoing high-dose chemotherapy and autologous hematopoietic stem cell transplantation: implications for patient selection

artículo científico publicado en 2003

Prediction of risk of distant recurrence using the 21-gene recurrence score in node-negative and node-positive postmenopausal patients with breast cancer treated with anastrozole or tamoxifen: a TransATAC study

artículo científico publicado en 2010

Prediction of survival by degree of reactivity to BCG in patients with metastatic breast cancer

artículo científico publicado en 1986

Predictive algorithms for adjuvant therapy: TransATAC.

artículo científico publicado en 2011

Predictors of local-regional recurrence after neoadjuvant chemotherapy and mastectomy without radiation

artículo científico publicado en 2002

Predictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy, and radiotherapy

artículo científico publicado en 2005

Pregnancy and offspring after adjuvant chemotherapy in breast cancer patients

artículo científico

Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease

artículo científico publicado en 2008

Primary chemotherapy for early and advanced breast cancer

artículo científico publicado en 1995

Primary chemotherapy in the treatment of breast cancer: the University of Texas M. D. Anderson Cancer Center experience.

artículo científico publicado en 2002

Primary tumor response to induction chemotherapy as a predictor of histological status of axillary nodes in operable breast cancer patients

scientific article published on 01 December 1999

Proceedings of the Fifth International Conference on Recent Advances and Future Directions in Endocrine Therapy for Breast Cancer: conference summary statement

artículo científico publicado en 2006

Proceedings of the Fourth International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: conference summary statement.

artículo científico publicado en 2005

Proceedings of the Third International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: Conference Summary Statement

artículo científico publicado en 2004

Prognosis of women with metastatic breast cancer by HER2 status and trastuzumab treatment: an institutional-based review

artículo científico publicado en 2009

Prognostic implications of pathological lymph node status after preoperative chemotherapy for operable T3N0M0 breast cancer

artículo científico publicado en 2000

Prognostic significance of phosphorylated P38 mitogen-activated protein kinase and HER-2 expression in lymph node-positive breast carcinoma

artículo científico publicado en 2004

Prognostic value of P53, MDM-2, and MUC-1 for patients with inflammatory breast carcinoma

artículo científico publicado en 2004

Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the Genomic Health recurrence score in early breast cancer

artículo científico publicado en 2011

Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors.

artículo científico publicado en 2006

Progress in inflammatory breast cancer: cause for cautious optimism

artículo científico publicado en 1986

Prospective assessment of cardiac toxicity during a randomized phase II trial of doxorubicin and paclitaxel in metastatic breast cancer

artículo científico publicado el 1 de octubre de 1997

Prospective evaluation of paclitaxel versus combination chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide as neoadjuvant therapy in patients with operable breast cancer.

artículo científico publicado en 1999

Prospective randomized trial of 5-fluorouracil, doxorubicin, and cyclophosphamide (FAC) versus paclitaxel and FAC (TFAC) in patients with operable breast cancer: impact of taxane chemotherapy on locoregional control

artículo científico publicado en 2011

Prospective randomized trial of paclitaxel alone versus 5-fluorouracil/doxorubicin/cyclophosphamide as induction therapy in patients with operable breast cancer

artículo científico publicado el 1 de octubre de 1997

Pulmonary toxicity of mitomycin

scientific article published on 01 January 1980

RESPONSE: re: randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma

scientific article published on 01 August 2000

Radiation-induced breast cancer

scientific article published on 01 June 1984

Randomized double‐blind phase 2 trial of 3 doses of TAS‐108 in patients with advanced or metastatic postmenopausal breast cancer ⬇️

artículo científico publicado el 1 de julio de 2012

Randomized trial of high-dose chemotherapy and autologous hematopoietic stem cell support for high-risk primary breast carcinoma: follow-up at 12 years

scientific article published on 01 June 2006

Randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma

scientific article published on 01 February 2000

Recent advances in adjuvant therapy of breast cancer

artículo científico publicado en 1999

Recent advances in the hormonal treatment of breast cancer

artículo científico publicado en 2008

Recent developments in breast cancer therapy

artículo científico publicado en 1999

Relationship between obesity and pathologic response to neoadjuvant chemotherapy among women with operable breast cancer.

artículo científico publicado en 2008

Relationship between quantitative estrogen and progesterone receptor expression and human epidermal growth factor receptor 2 (HER-2) status with recurrence in the Arimidex, Tamoxifen, Alone or in Combination trial

artículo científico publicado en 2008

Relative value of physical examination, mammography, and breast sonography in evaluating the size of the primary tumor and regional lymph node metastases in women receiving neoadjuvant chemotherapy for locally advanced breast carcinoma.

artículo científico publicado en 1997

Residual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease-free survival in patients with locally advanced breast cancer

artículo científico publicado en 1998

Residual risk of breast cancer recurrence 5 years after adjuvant therapy

artículo científico publicado en 2008

Response to Induction Chemotherapy in Black and White Patients with Locally Advanced Breast Cancer

scientific article published on 01 July 2000

Response to hormonal therapy as a prognostic factor for metastatic breast cancer treated with combination chemotherapy

artículo científico publicado en 1980

Results and long term follow-up for 1581 patients with metastatic breast carcinoma treated with standard dose doxorubicin-containing chemotherapy: a reference

artículo científico publicado en 1999

Results of adjuvant chemotherapy trials in breast cancer at M. D. Anderson Hospital and Tumor Institute

artículo científico publicado en 1986

Risk factors for joint symptoms in patients enrolled in the ATAC trial: a retrospective, exploratory analysis

artículo científico publicado en 2008

Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511).

artículo científico publicado en 2016

Role of adjuvant chemotherapy in male breast cancer

scientific article published on 01 October 1989

Role of axillary lymph node dissection after tumor downstaging with induction chemotherapy for locally advanced breast cancer.

artículo científico publicado en 1998

SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.

artículo científico publicado en 2017

Screening for Cardiac Risk Before Anthracycline Administration: What Are The Real Benefits? ⬇️

artículo científico publicado el 29 de noviembre de 2011

Second International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: summary consensus statement.

artículo científico publicado en 2003

Second neoplasms after adjuvant chemotherapy for operable breast cancer

artículo científico publicado en 1986

Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer

artículo científico publicado en 2000

Sequence-dependent alteration of doxorubicin pharmacokinetics by paclitaxel in a phase I study of paclitaxel and doxorubicin in patients with metastatic breast cancer

artículo científico publicado en 1996

Sequencing of chemotherapy and radiation in lymph node-negative breast cancer

artículo científico publicado en 1999

Sequential continuous infusion with doxorubicin and vinblastine: an effective chemotherapy combination for patients with advanced breast cancer previously treated with cyclophosphamide, methotrexate, 5-FU, vincristine, and prednisone

artículo científico publicado en 1984

Sequential cyclic combined hormonal therapy for metastatic breast cancer

Sequential multiagent chemotherapy incorporating cisplatin, doxorubicin, and cyclophosphamide in the treatment of metastatic breast cancer

artículo científico publicado en 1988

Sequential paclitaxel reduces recurrence and mortality in women with early breast cancer

artículo científico publicado en 2003

Serial plasma carcinoembryonic antigen measurements during treatment of metastatic breast cancer

scientific article published on 01 April 1983

Short-term biomarker modulation prevention study of anastrozole in women at increased risk for second primary breast cancer

artículo científico publicado en 2011

Significance of drug dose, timing and radiotherapy in adjuvant therapy of breast cancer

artículo científico publicado en 1984

Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer

artículo científico publicado en 2005

Single-nucleotide polymorphism biomarkers of adjuvant anastrozole-induced estrogen suppression in early breast cancer

artículo científico publicado en 2020

Sixteen-week, dose-intense chemotherapy in adjuvant treatment of breast cancer

scientific article published on 01 July 1990

Spontaneous regression of breast carcinoma

scientific article published on 01 November 1978

Spontaneous regression of breast carcinoma: follow-up report and literature review

artículo científico publicado en 1982

Staging of breast cancer in the neoadjuvant setting

artículo científico publicado en 2008

Subclinical hepatic toxicity during combination chemotherapy for breast cancer

artículo científico publicado en 1986

Summary of aromatase inhibitor clinical trials in postmenopausal women with early breast cancer

artículo científico publicado en 2008

Surgical conservation planning after neoadjuvant chemotherapy for stage II and operable stage III breast carcinoma

artículo científico publicado en 2001

T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy

artículo científico publicado en 2004

TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression

artículo científico publicado en 2013

Tamoxifen and toremifene in breast cancer: comparison of safety and efficacy ⬇️

artículo científico publicado el 1 de enero de 1998

Tamoxifen therapy for patients with breast cancer

artículo científico publicado en 2013

Tamoxifen-induced hypercalcemia in breast cancer

artículo científico publicado en 1981

Ten-year results of FAC adjuvant chemotherapy trial in breast cancer

scientific article published on 01 April 1989

The M. D. Anderson Cancer Center experience with Taxol in metastatic breast cancer

artículo científico publicado en 1993

The University of Texas M.D. Anderson Cancer Center experience with paclitaxel in breast cancer

artículo científico publicado en 1997

The correlation of axillary ultrasonography with histologic breast cancer downstaging after induction chemotherapy

artículo científico publicado en 2000

The feasibility of minimally invasive surgery for stage IIA, IIB, and IIIA breast carcinoma patients after tumor downstaging with induction chemotherapy

scientific article published on 01 March 2000

The impact of hormone receptor status on the clinical efficacy of the new-generation aromatase inhibitors: a review of data from first-line metastatic disease trials in postmenopausal women

artículo científico publicado en 2004

The management of locally advanced breast cancer: a combined modality approach

artículo científico publicado en 1984

The natural history of breast carcinoma in patients with > or = 10 metastatic axillary lymph nodes before and after the advent of adjuvant therapy: a multiinstitutional retrospective study

artículo científico publicado en 2005

The order of administration of chemotherapy and radiation and its effect on the local control of operable breast cancer

artículo científico publicado en 1993

The prognostic significance of lymph node metastases after preoperative chemotherapy for locally advanced breast cancer

artículo científico publicado en 1989

The prognostic significance of sialyl-tn Antigen in women treated with breast carcinoma treated with adjuvant chemotherapy ⬇️

artículo científico publicado el 15 de diciembre de 1997

The role of aromatase inhibitors in the adjuvant treatment of breast carcinoma: the M. D. Anderson Cancer Center evidence-based approach

artículo científico publicado en 2004

The role of serum CEA as a prognostic indicator in stage II and III breast cancer patients treated with adjuvant chemotherapy

scientific article published on 01 March 1989

The safety of breast-conserving surgery in patients who achieve a complete pathologic response after neoadjuvant chemotherapy

artículo científico publicado en 2006

The use of alternate, non-cross-resistant adjuvant chemotherapy on the basis of pathologic response to a neoadjuvant doxorubicin-based regimen in women with operable breast cancer: long-term results from a prospective randomized trial

artículo científico publicado en 2004

Total RNA yield and microarray gene expression profiles from fine-needle aspiration biopsy and core-needle biopsy samples of breast carcinoma

artículo científico publicado en 2003

Treatment of estrogen receptor-negative or hormonally refractory breast cancer with double high-dose chemotherapy intensification and bone marrow support

artículo científico publicado en 1990

Treatment of locoregionally advanced breast cancer with surgery, radiotherapy, and combination chemoimmunotherapy

artículo científico publicado en 1983

Treatment-related leukemia in breast cancer patients treated with fluorouracil-doxorubicin-cyclophosphamide combination adjuvant chemotherapy: the University of Texas M.D. Anderson Cancer Center experience

artículo científico publicado en 1996

Trends for Inflammatory Breast Cancer: Is Survival Improving?

artículo científico publicado en 2007

Trends in survival over the past two decades among white and black patients with newly diagnosed stage IV breast cancer

artículo científico publicado en 2008

Trilostane with hydrocortisone in treatment of metastatic breast cancer

artículo científico publicado en 1989

Trioxifene mesylate in the treatment of advanced breast cancer

artículo científico publicado en 1986

Tumor-associated fever in breast cancer

artículo científico publicado en 1984

Update on the management of inflammatory breast cancer

artículo científico publicado en 2003

Use of Taxol (paclitaxel) in breast cancer

scientific article published on 01 October 1994

Use of aromatase inhibitors in postmenopausal women with advanced breast cancer ⬇️

artículo científico publicado el 1 de noviembre de 1997

Use of prognostic factors in analysis of historical control studies

artículo científico publicado en 1980

Use of tamoxifen for breast cancer: twenty-eight years later

artículo científico publicado en 1995

Using response to primary chemotherapy to select postoperative therapy: long-term results from a prospective phase II trial in locally advanced primary breast cancer

artículo científico publicado en 2008

Validation of a novel staging system for disease-specific survival in patients with breast cancer treated with neoadjuvant chemotherapy

artículo científico publicado en 2011

Variation in anastrozole metabolism and pharmacodynamics in women with early breast cancer

artículo científico publicado en 2010

Vindesine in the treatment of refractory breast cancer: improvement in therapeutic index with continuous 5-day infusion.

artículo científico publicado en 1981

Weekly paclitaxel improves pathologic complete remission in operable breast cancer when compared with paclitaxel once every 3 weeks

artículo científico publicado en 2005

Which threshold for ER positivity? a retrospective study based on 9639 patients

artículo científico publicado en 2014

Women age < or = 35 years with primary breast carcinoma: disease features at presentation

artículo científico publicado en 2005

p53 expression as a prognostic marker in inflammatory breast cancer

artículo científico publicado en 2004

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda